annual CAPEX:
$1.12M-$1.04M(-48.15%)Summary
- As of today (May 29, 2025), BCRX annual capital expenditures is $1.12 million, with the most recent change of -$1.04 million (-48.15%) on December 31, 2024.
- During the last 3 years, BCRX annual CAPEX has fallen by -$1.26 million (-52.87%).
- BCRX annual CAPEX is now -78.70% below its all-time high of $5.28 million, reached on December 31, 2016.
Performance
BCRX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$143.00K-$532.00K(-78.81%)Summary
- As of today (May 29, 2025), BCRX quarterly capital expenditures is $143.00 thousand, with the most recent change of -$532.00 thousand (-78.81%) on March 31, 2025.
- Over the past year, BCRX quarterly CAPEX has dropped by -$92.00 thousand (-39.15%).
- BCRX quarterly CAPEX is now -96.47% below its all-time high of $4.05 million, reached on December 31, 2015.
Performance
BCRX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.03M-$92.00K(-8.19%)Summary
- As of today (May 29, 2025), BCRX TTM capital expenditures is $1.03 million, with the most recent change of -$92.00 thousand (-8.19%) on March 31, 2025.
- Over the past year, BCRX TTM CAPEX has dropped by -$1.21 million (-53.99%).
- BCRX TTM CAPEX is now -88.93% below its all-time high of $9.32 million, reached on September 30, 2016.
Performance
BCRX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
BCRX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.1% | -39.1% | -54.0% |
| 3 y3 years | -52.9% | -64.8% | -61.7% |
| 5 y5 years | +227.7% | +23.3% | +182.0% |
BCRX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.9% | at low | -85.5% | +142.4% | -61.7% | +2.9% |
| 5 y | 5-year | -52.9% | +227.7% | -87.1% | +142.4% | -61.7% | +194.9% |
| alltime | all time | -78.7% | +3646.7% | -96.5% | +211.5% | -88.9% | +9281.8% |
BCRX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $143.00K(-78.8%) | $1.03M(-8.2%) |
| Dec 2024 | $1.12M(-48.2%) | $675.00K(+1044.1%) | $1.12M(+12.1%) |
| Sep 2024 | - | $59.00K(-61.9%) | $1.00M(-48.1%) |
| Jun 2024 | - | $155.00K(-34.0%) | $1.93M(-13.9%) |
| Mar 2024 | - | $235.00K(-57.6%) | $2.24M(+3.5%) |
| Dec 2023 | $2.17M(+60.5%) | $554.00K(-43.9%) | $2.17M(+1.3%) |
| Sep 2023 | - | $987.00K(+111.3%) | $2.14M(+61.1%) |
| Jun 2023 | - | $467.00K(+191.9%) | $1.33M(+20.2%) |
| Mar 2023 | - | $160.00K(-69.6%) | $1.10M(-18.2%) |
| Dec 2022 | $1.35M(-43.4%) | $526.00K(+200.6%) | $1.35M(-30.1%) |
| Sep 2022 | - | $175.00K(-28.3%) | $1.93M(-8.9%) |
| Jun 2022 | - | $244.00K(-39.9%) | $2.12M(-21.1%) |
| Mar 2022 | - | $406.00K(-63.4%) | $2.69M(+12.9%) |
| Dec 2021 | $2.38M(+364.0%) | $1.11M(+203.6%) | $2.38M(+66.6%) |
| Sep 2021 | - | $365.00K(-55.1%) | $1.43M(+15.6%) |
| Jun 2021 | - | $813.00K(+721.2%) | $1.24M(+149.3%) |
| Mar 2021 | - | $99.00K(-36.1%) | $497.00K(-3.3%) |
| Dec 2020 | $514.00K(+49.9%) | $155.00K(-9.9%) | $514.00K(+17.1%) |
| Sep 2020 | - | $172.00K(+142.3%) | $439.00K(+25.4%) |
| Jun 2020 | - | $71.00K(-38.8%) | $350.00K(-4.4%) |
| Mar 2020 | - | $116.00K(+45.0%) | $366.00K(+6.7%) |
| Dec 2019 | $343.00K(-6.3%) | $80.00K(-3.6%) | $343.00K(-6.5%) |
| Sep 2019 | - | $83.00K(-4.6%) | $367.00K(+12.9%) |
| Jun 2019 | - | $87.00K(-6.5%) | $325.00K(-23.3%) |
| Mar 2019 | - | $93.00K(-10.6%) | $424.00K(+15.8%) |
| Dec 2018 | $366.00K(+11.6%) | $104.00K(+153.7%) | $366.00K(-2.9%) |
| Sep 2018 | - | $41.00K(-78.0%) | $377.00K(-28.2%) |
| Jun 2018 | - | $186.00K(+431.4%) | $525.00K(+45.8%) |
| Mar 2018 | - | $35.00K(-69.6%) | $360.00K(+9.8%) |
| Dec 2017 | $328.00K(-93.8%) | $115.00K(-39.2%) | $328.00K(+54.7%) |
| Sep 2017 | - | $189.00K(+800.0%) | $212.00K(+5.0%) |
| Jun 2017 | - | $21.00K(+600.0%) | $202.00K(-90.0%) |
| Mar 2017 | - | $3000.00(-400.0%) | $2.02M(-61.7%) |
| Dec 2016 | $5.28M(+3.0%) | -$1000.00(-100.6%) | $5.28M(-43.4%) |
| Sep 2016 | - | $179.00K(-90.3%) | $9.32M(+0.4%) |
| Jun 2016 | - | $1.84M(-43.6%) | $9.29M(+18.8%) |
| Mar 2016 | - | $3.26M(-19.4%) | $7.82M(+52.6%) |
| Dec 2015 | $5.12M(+4732.1%) | $4.05M(+2749.3%) | $5.12M(+348.9%) |
| Sep 2015 | - | $142.00K(-61.5%) | $1.14M(+10.5%) |
| Jun 2015 | - | $369.00K(-34.7%) | $1.03M(+55.6%) |
| Mar 2015 | - | $565.00K(+769.2%) | $664.00K(+526.4%) |
| Dec 2014 | $106.00K(+253.3%) | $65.00K(+91.2%) | $106.00K(+135.6%) |
| Sep 2014 | - | $34.00K(>+9900.0%) | $45.00K(+309.1%) |
| Jun 2014 | - | $0.00(-100.0%) | $11.00K(-70.3%) |
| Mar 2014 | - | $7000.00(+75.0%) | $37.00K(+23.3%) |
| Dec 2013 | $30.00K(-73.5%) | $4000.00(>+9900.0%) | $30.00K(+25.0%) |
| Sep 2013 | - | $0.00(-100.0%) | $24.00K(-20.0%) |
| Jun 2013 | - | $26.00K(-1400.0%) | $30.00K(-73.5%) |
| Dec 2012 | $113.00K(+105.5%) | -$2000.00(-133.3%) | $113.00K(-2.6%) |
| Sep 2012 | - | $6000.00(-85.0%) | $116.00K(+4.5%) |
| Jun 2012 | - | $40.00K(-42.0%) | $111.00K(+18.1%) |
| Mar 2012 | - | $69.00K(+6800.0%) | $94.00K(+70.9%) |
| Dec 2011 | $55.00K(-83.1%) | $1000.00(0.0%) | $55.00K(-17.9%) |
| Sep 2011 | - | $1000.00(-95.7%) | $67.00K(-48.9%) |
| Jun 2011 | - | $23.00K(-23.3%) | $131.00K(-51.8%) |
| Mar 2011 | - | $30.00K(+130.8%) | $272.00K(-16.3%) |
| Dec 2010 | $325.00K(-46.2%) | $13.00K(-80.0%) | $325.00K(-19.7%) |
| Sep 2010 | - | $65.00K(-60.4%) | $404.70K(-15.6%) |
| Jun 2010 | - | $164.00K(+97.6%) | $479.70K(-18.9%) |
| Mar 2010 | - | $83.00K(-10.5%) | $591.70K(-2.0%) |
| Dec 2009 | $603.70K | $92.70K(-33.8%) | $603.70K(+3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $140.00K(-49.3%) | $583.30K(-34.4%) |
| Jun 2009 | - | $276.00K(+190.5%) | $889.30K(-22.2%) |
| Mar 2009 | - | $95.00K(+31.4%) | $1.14M(-5.7%) |
| Dec 2008 | $1.21M(-63.7%) | $72.30K(-83.8%) | $1.21M(-54.0%) |
| Sep 2008 | - | $446.00K(-15.8%) | $2.63M(-22.5%) |
| Jun 2008 | - | $530.00K(+223.2%) | $3.40M(+5.2%) |
| Mar 2008 | - | $164.00K(-89.0%) | $3.23M(-3.4%) |
| Dec 2007 | $3.34M(+117.9%) | $1.49M(+23.4%) | $3.34M(+36.6%) |
| Sep 2007 | - | $1.21M(+234.5%) | $2.45M(+71.7%) |
| Jun 2007 | - | $362.00K(+30.7%) | $1.43M(+16.9%) |
| Mar 2007 | - | $277.00K(-53.7%) | $1.22M(-20.5%) |
| Dec 2006 | $1.53M(+2921.1%) | $597.70K(+216.2%) | $1.53M(+89.8%) |
| Sep 2006 | - | $189.00K(+21.2%) | $808.80K(+12.2%) |
| Jun 2006 | - | $156.00K(-73.6%) | $720.80K(+19.8%) |
| Mar 2006 | - | $592.00K(-561.8%) | $601.80K(+1084.6%) |
| Dec 2005 | $50.80K(-81.6%) | -$128.20K(-226.9%) | $50.80K(-82.4%) |
| Sep 2005 | - | $101.00K(+173.0%) | $288.90K(+36.3%) |
| Jun 2005 | - | $37.00K(-9.8%) | $211.90K(+9.3%) |
| Mar 2005 | - | $41.00K(-62.7%) | $193.90K(-29.7%) |
| Dec 2004 | $275.90K(+433.7%) | $109.90K(+357.9%) | $275.90K(+49.4%) |
| Sep 2004 | - | $24.00K(+26.3%) | $184.70K(+10.8%) |
| Jun 2004 | - | $19.00K(-84.6%) | $166.70K(+9.9%) |
| Mar 2004 | - | $123.00K(+557.8%) | $151.70K(+193.4%) |
| Dec 2003 | $51.70K(-87.3%) | $18.70K(+211.7%) | $51.70K(+57.1%) |
| Sep 2003 | - | $6000.00(+50.0%) | $32.90K(+27.0%) |
| Jun 2003 | - | $4000.00(-82.6%) | $25.90K(-86.4%) |
| Mar 2003 | - | $23.00K(<-9900.0%) | $190.90K(-53.2%) |
| Dec 2002 | $407.90K(-84.3%) | -$100.00(-90.0%) | $407.90K(-65.5%) |
| Sep 2002 | - | -$1000.00(-100.6%) | $1.18M(-48.0%) |
| Jun 2002 | - | $169.00K(-29.6%) | $2.28M(+1.9%) |
| Mar 2002 | - | $240.00K(-69.0%) | $2.23M(-14.2%) |
| Dec 2001 | $2.60M(-4.4%) | $775.40K(-28.9%) | $2.60M(-11.4%) |
| Sep 2001 | - | $1.09M(+759.1%) | $2.94M(+7.7%) |
| Jun 2001 | - | $127.00K(-79.2%) | $2.73M(-11.5%) |
| Mar 2001 | - | $611.00K(-45.0%) | $3.09M(+13.3%) |
| Dec 2000 | $2.72M(+172.3%) | $1.11M(+26.1%) | $2.72M(+28.9%) |
| Sep 2000 | - | $881.00K(+82.8%) | $2.11M(+58.7%) |
| Jun 2000 | - | $482.00K(+93.6%) | $1.33M(+26.9%) |
| Mar 2000 | - | $249.00K(-50.2%) | $1.05M(+4.9%) |
| Dec 1999 | $1.00M(+150.0%) | $500.00K(+400.0%) | $1.00M(+100.0%) |
| Sep 1999 | - | $100.00K(-50.0%) | $500.00K(0.0%) |
| Jun 1999 | - | $200.00K(0.0%) | $500.00K(+25.0%) |
| Mar 1999 | - | $200.00K(>+9900.0%) | $400.00K(0.0%) |
| Dec 1998 | $400.00K(-63.6%) | $0.00(-100.0%) | $400.00K(-20.0%) |
| Sep 1998 | - | $100.00K(0.0%) | $500.00K(0.0%) |
| Jun 1998 | - | $100.00K(-50.0%) | $500.00K(-50.0%) |
| Mar 1998 | - | $200.00K(+100.0%) | $1.00M(-9.1%) |
| Dec 1997 | $1.10M(+266.7%) | $100.00K(0.0%) | $1.10M(0.0%) |
| Sep 1997 | - | $100.00K(-83.3%) | $1.10M(0.0%) |
| Jun 1997 | - | $600.00K(+100.0%) | $1.10M(+83.3%) |
| Mar 1997 | - | $300.00K(+200.0%) | $600.00K(+100.0%) |
| Dec 1996 | $300.00K(+50.0%) | $100.00K(0.0%) | $300.00K(+50.0%) |
| Sep 1996 | - | $100.00K(0.0%) | $200.00K(0.0%) |
| Jun 1996 | - | $100.00K(>+9900.0%) | $200.00K(0.0%) |
| Dec 1995 | $200.00K(-50.0%) | $0.00(-100.0%) | $200.00K(-33.3%) |
| Sep 1995 | - | $100.00K(>+9900.0%) | $300.00K(0.0%) |
| Jun 1995 | - | $0.00(-100.0%) | $300.00K(-25.0%) |
| Mar 1995 | - | $100.00K(0.0%) | $400.00K(0.0%) |
| Dec 1994 | $400.00K | $100.00K(0.0%) | $400.00K(+33.3%) |
| Sep 1994 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Jun 1994 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1994 | - | $100.00K | $100.00K |
FAQ
- What is BioCryst Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals annual CAPEX year-on-year change?
- What is BioCryst Pharmaceuticals quarterly capital expenditures?
- What is the all time high quarterly CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals quarterly CAPEX year-on-year change?
- What is BioCryst Pharmaceuticals TTM capital expenditures?
- What is the all time high TTM CAPEX for BioCryst Pharmaceuticals?
- What is BioCryst Pharmaceuticals TTM CAPEX year-on-year change?
What is BioCryst Pharmaceuticals annual capital expenditures?
The current annual CAPEX of BCRX is $1.12M
What is the all time high annual CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high annual capital expenditures is $5.28M
What is BioCryst Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, BCRX annual capital expenditures has changed by -$1.04M (-48.15%)
What is BioCryst Pharmaceuticals quarterly capital expenditures?
The current quarterly CAPEX of BCRX is $143.00K
What is the all time high quarterly CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high quarterly capital expenditures is $4.05M
What is BioCryst Pharmaceuticals quarterly CAPEX year-on-year change?
Over the past year, BCRX quarterly capital expenditures has changed by -$92.00K (-39.15%)
What is BioCryst Pharmaceuticals TTM capital expenditures?
The current TTM CAPEX of BCRX is $1.03M
What is the all time high TTM CAPEX for BioCryst Pharmaceuticals?
BioCryst Pharmaceuticals all-time high TTM capital expenditures is $9.32M
What is BioCryst Pharmaceuticals TTM CAPEX year-on-year change?
Over the past year, BCRX TTM capital expenditures has changed by -$1.21M (-53.99%)